Skip to main content
. 2018 Mar 5;39(5):2127–2135. doi: 10.3892/or.2018.6294

Figure 1.

Figure 1.

Reproduction of TCGA database using cBioPortal shows that the association with YWHAZ amplification had (A) relatively worse survival outcomes among breast, lung and prostate cancer, but (B) a better survival trend in bladder cancers. (C) YWHAZ amplification was the dominant gene alteration found among breast, bladder, prostate and lung cancer. TCGA, The Cancer Genome Atlas; OS, overall survival; DFS, disease-free survival.